Hypothesis driven drug discovery
نویسندگان
چکیده
منابع مشابه
Ethnobotany, Ethnopharmacology and Drug Discovery
This manuscript is a review of a number of ethnobotany and ethnopharmacology texts and papers in order to arrive at current understanding and scope of ethnobotany and ethnopharmacology. It includes either a brief definition of both fields and presenting some examples on them. Also it has a glimpse on the geographical coverage of research works throughout the world, important issue of prope...
متن کاملHypothesis-driven medication discovery for the treatment of psychostimulant addiction.
Psychostimulant abuse is a serious social and health problem, for which no effective treatments currently exist. A number of review articles have described predominantly 'clinic'-based pharmacotherapies for the treatment of psychostimulant addiction, but none have yet been shown to be definitively effective for use in humans. In the present article, we review various 'hypothesis'- or 'mechanism...
متن کاملGoal-Driven Hypothesis Testing in a Rule Discovery Task
The Wason 2-4-6 task was embedded in a practical reasoning scenario where number sequences had well defined utilities in the process of achieving a goal. Reasoners’ hypothesis-testing behaviour was clearly goal-driven and was significantly influenced by whether the utilities favoured positive or negative sequences. In the version of the scenario where generating positive sequences had greater b...
متن کاملCausality driven data integration for adverse drug reaction discovery
S : scientific #bd14 | big data conference 44 Dr Chen Wang Senior Research Scientist CSIRO Computational Informatics Dr Chen Wang is a Senior Research Scientist at CSIRO Computational Informatics. He received his PhD from Nanjing University. His research interests are primarily in distributed, parallel and trustworthy systems. His current work focus on data analytics systems for drug adverse re...
متن کاملNetwork-Driven Analysis Methods and their Application to Drug Discovery
Drug discovery and development face tremendous challenges to find promising intervention points for important diseases. Any therapeutic agent targeting such an intervention point must prove its efficacy and safety in patients. Success rates measured from first studies in human to registration average around 10% only. Over the last decade, massive knowledge on biological systems has been accumul...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Microbiology Australia
سال: 2002
ISSN: 1324-4272
DOI: 10.1071/ma02508